Opinion

Video

Topical Treatments for Psoriasis for Patients With Skin of Color

Dr Stein Gold and Dr Shahriari review steroidal and non-steroidal topical treatments that are available for use in psoriasis.

This is a video synopsis/summary of a panel discussion involving Linda Stein Gold, MD; Mona Shahriari, MD, FAAD; and Seemal Desai, MD.

In discussing the treatment of psoriasis in patients with skin of color, the conversation highlights the challenges and considerations specific to this population. While topicals are essential for treating plaque psoriasis, especially when combined with systemic therapy, scalp psoriasis presents unique difficulties, particularly for patients with afro-textured hair.

Formulation plays a crucial role, with patients often preferring oils, foams, or lotions over creams or ointments for the scalp. Hair care practices and styling preferences further complicate treatment adherence, requiring dermatologists to consider individual patient habits.

Concerns about hypopigmentation and other pigmentary alterations limit the use of traditional topical corticosteroids in patients with skin of color. Dermatologists may have a lower threshold for initiating systemic therapy due to these concerns.

Combination therapy, such as combining non-steroidal products with steroids, can enhance efficacy while minimizing irritation. Newer non-steroidal topicals offer promising options, with once-daily application and minimal risk of pigmentary sequelae.

Clinical experience suggests that these newer topicals can normalize skin color without exacerbating pigmentary changes, offering a valuable alternative for patients concerned about adverse events from traditional treatments.

Overall, the conversation underscores the importance of tailoring treatment to the specific needs and characteristics of patients with skin of color, ensuring both efficacy and safety in managing psoriasis.

Video synopsis is AI-generated and reviewed by HCPLive editorial staff.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Implications of Findings on Patient-Reported Outcomes for Roflumilast Foam, with Melinda Gooderham, MD
New Findings on Psoriasis Outcomes for Roflumilast Foam 0.3%, with Melinda Gooderham, MD
© 2024 MJH Life Sciences

All rights reserved.